News Focus
News Focus
Followers 744
Posts 63588
Boards Moderated 9
Alias Born 10/05/2009

Re: ~ Blue ~ post# 187398

Sunday, 01/05/2020 6:46:50 PM

Sunday, January 05, 2020 6:46:50 PM

Post# of 197886
Two of my favorite stocks $SNPW, and $MILV. SNPW is one where I have proof of (a copy from the state) of the RI/EPA New Source review air permit application for the 20 Million dollar MedWaste to energy waste to syn gas to fuel pump to energy (electric power generator running on syn gas from the pyrolyzed waste) cutting edge plant being installed already, and shares at 80+ discount in the load like a man zone!!!!

$MILV R/M custodian play where we found out what is inbound behind the curtain!!!

The MILV story?

$MILV ***Brain Trauma Repair***

#NFL #TBI #LarryKubin #Univ of #PennMed #Liposome #Patent

That contract with 'University of Penn' most likely stems from Michael W. Fountain's patent application for nanoparticle liposomes that can take their therapeutic compounds and deliver them wherever they need to go in the brain.

How does that work and what did Michael W. Fountain develop with this new patent, one of 131 Issued US patents in his resume?

Most people are unaware that Vitamin E is essential for the bodies general over health, along with other Vitamin agents like A and C. The reason is because Vitamin E donates hydrogen for cell energy and repair.

Chief Scientist, Michael W. Fountain PhD, has licensed his patent to directly tackle this specific deficiency in medical application and medications. Studies have been done at Oregon State University back in 1987 that showed that Vitamin E efficacy in cell culture, simply wasn't being seen in rodent populations testing due to the "inactivity" of the Vitamin E and Vitamin E succinate compounds they were using.

What Dr. Michael W. Fountain and a research team were able to develop was a "Vitamin E Phosphate" compound that wasn't inert, nor harmful to the liver upon breakdown.

Thus it could repair and now protect the liver when drugs like tetrahydroaminoacridine (THA) (A compound used effectively used to treat ALZHEIMERS, but toxic to the liver
).

He has developed a liposome with

1. Long Shelf life (24 months),
2. Durability and Efficacy
3. Mass Production
4. One-step production
5. A protective compound for brain damage
6. Small liposome that can pass through BBB -- blood brain barrier

All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today